Seroquel XR

Medicinal product

(Invented) name

Seroquel XR

Active substance (s)

Kvetiapinas

Strength

150 mg

Pharmaceutical form

pailginto atpalaidavimo tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

N05AH04, Quetiapine

Marketing authorisation holder

AstraZeneca UK Limited, Jungtinė Karalystė

Date of authorisation

2010-06-15

Date of renewal

2016-04-29

Documents

0964_1_6 Seroquel XR_atpalaid tab PCS PL 180806.docx

0964_1_6 Pakuotės lapelis 180806.docx

Stage

Išregistruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

NL/H/0156/012/MR

Marketing authorisation procedure

Savitarpio pripažinimo procedūra

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Kvetiapinas	150 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
30868	33323	1033323	lizdinė plokštelė	N10		Receptinis	LT/1/08/0964/005	Netiekiama	-	-	No	-	-
41439	55197	1055197	lizdinė plokštelė	N60		Receptinis	LT/1/08/0964/006	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2018-09-05	Išregistruotas
2016-04-29	Perregistruotas
2010-06-15	Registruotas